← Browse by Condition
Medical Condition

acute coronary syndrome

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 4, Phase 2, Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for acute coronary syndrome sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — acute coronary syndrome Clinical Trials

How many clinical trials are currently recruiting for acute coronary syndrome?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for acute coronary syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for acute coronary syndrome?
acute coronary syndrome research spans Phase 2 (2 trials), Phase 3 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a acute coronary syndrome clinical trial?
Eligibility criteria for acute coronary syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Phase 3
2
Phase 4
1
Top Sponsors
Qilu Hospital of Shandong University 1 trial
University of Sao Paulo 1 trial
University of Texas Southwestern Medical Center 1 trial
Action, France 1 trial
Radboud University Medical Center 1 trial

Recruiting Clinical Trials

NCT04728516 Phase 4
Recruiting
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
Enrollment
2,600 pts
Location
China
Sponsor
Qilu Hospital of Shandong Univ...
View Trial →
NCT06286878 Phase 2, Phase 3
Recruiting
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
Enrollment
80 pts
Location
Brazil
Sponsor
University of Sao Paulo
View Trial →
NCT07032389 Phase 2
Recruiting
A Polypill for Acute Coronary Syndrome
Enrollment
1,000 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →
NCT02762162
Recruiting
Registry of Coronary Artery Ill Patients With Platelet Test Results
Enrollment
5,000 pts
Location
France
Sponsor
Action, France
View Trial →
NCT06512493
Recruiting
South East (Zuid Oost) Netherlands Heart Registry
Enrollment
99,999 pts
Location
Netherlands
Sponsor
Radboud University Medical Cen...
View Trial →
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Enrollment
2,000 pts
Location
United States, Canad...
Sponsor
DalCor Pharmaceuticals
View Trial →
NCT06673381
Recruiting
High Sensitive C-reactive Protein to Albumin Ratio in Acute Coronary Syndrome
Enrollment
240 pts
Location
Egypt
Sponsor
Sohag University
View Trial →

Related Conditions

myocardial infarction (2) helicobacter pylori infection (1) diabetes (1) ventricular dysfunction (1) percutaneous coronary intervention (1) coronary artery disease (1) chronic coronary syndrome (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology